WallStreetZenWallStreetZen

NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RVPH earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$40.1M
Current Profit Margin
0%

RVPH Return on Equity

Current Company
N/A
Current Industry
16.9%
Current Market
28.2%

Be the first to know when RVPH announces earnings.

RVPH Return on Assets

Current Company
-294.7%
Current Industry
3.2%
RVPH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RVPH Return on Capital Employed

Current Company
4,025.64%
Current Industry
-42.5%
RVPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RVPH vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RVPH$0.00-$40.07M-$40.09MN/AN/A
OKYO$0.00-$13.18M-$13.27MN/AN/A
ACHL$0.00-$59.22M-$64.43MN/AN/A
EVGN$9.19M-$18.22M-$21.47M+39.67%N/A
LPCN$4.71M-$8.94M-$8.97M+131.17%N/A
View Top Biotech Stocks

Reviva Pharmaceuticals Holdings Earnings & Revenue FAQ

What were RVPH's earnings last quarter?

On Invalid Date, Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q1 2024 earnings per share (EPS) of -$0.25, up 19.35% year over year. Total Reviva Pharmaceuticals Holdings earnings for the quarter were -$7.43 million. In the same quarter last year, Reviva Pharmaceuticals Holdings's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.

What was RVPH's earnings growth in the past year?

As of Q2 2024, Reviva Pharmaceuticals Holdings's earnings has grown year over year. Reviva Pharmaceuticals Holdings's earnings in the past year totalled -$40.09 million.

What was RVPH's revenue last quarter?

On Invalid Date, Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Reviva Pharmaceuticals Holdings's revenue was $0.00.

What was RVPH's revenue growth in the past year?

As of Q2 2024, Reviva Pharmaceuticals Holdings's revenue has grown null year over year. Reviva Pharmaceuticals Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.